John Murphy, President The COVID Long-haul Foundation Abstract The SARS-CoV-2 spike (S) protein is the principal mediator of viral entry and a key determinant of COVID-19 pathogenesis. This article provides…[...]
Read More
John Murphy, President, The COVID Long-haul Foundation Chronic pruritus, or persistent itching, has emerged as a notable symptom among individuals experiencing long COVID. This condition, often overlooked, can significantly impact…[...]
Read More
John Murphy, President The COVID Long-haul Foundation 🧬 Introduction In the wake of the COVID-19 pandemic, a new clinical entity emerged—Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC). Characterized…[...]
Read More
Aikaterini Dimitrakopoulou • Antigoni Sarantaki • Christina I. Nanou • Vasiliki E. Georgakopoulou • Chrysoula Taskou • Maria Chouli • Athina Diamanti, , DOI: 10.7759/cureus.93877 Abstract Long sequelae of COVID-19 (Long COVID), or post-acute sequelae of SARS-CoV-2 infection, encompasses a wide range of…[...]
Read More
🔗 Key Findings from NIH RECOVER Initiative Adults with OSA have a significantly higher risk of developing long COVID: 75% increased risk in the N3C cohort (1.7 million adults) 12%…[...]
Read More
A blood test has achieved 96% accuracy in diagnosing the condition in a small study of individuals. What does the test detect, and is it a biomarker of the condition?…[...]
Read More
John Murphy, The COVID 19 Long-haul Foundation Abstract The rapid deployment of mRNA vaccines against SARS-CoV-2 marked a historic milestone in biotechnology. While these vaccines have demonstrated minor efficacy in…[...]
Read More
Data on how parts of a Pfizer-BioNTech COVID-19 vaccine spread in the bodies of mice were withheld from regulatory submissions to the U.S. Food and Drug Administration, according to a new…[...]
Read More
By Amina Niasse NEW YORK, Oct 14 (Reuters) - Americans headed to pharmacies for COVID-19 vaccines are running into roadblocks and confusion due to new U.S. guidance that abandoned broad support…[...]
Read More
Reactive arthritis can develop after COVID-19 due to immune system activation. The virus triggers inflammation that may mistakenly target joint tissues, even if joints weren’t affected during the acute illness2.…[...]
Read More